Webb31 dec. 2024 · For the year ended 31 December 2024. The directors present their annual report and audited financial statements for Prothena Corporation plc ("Prothena" or "the Company") and its subsidiary undertakings (collectively "the group") for the year ended December 31, 2024. The consolidated financial statements can be found from pages 59 … Webb7 mars 2024 · Chief Regulatory Officer at Prothena . Ms. Karp has served as our Chief Regulatory Officer since 2016. Prior to joining Prothena, she was an independent regulatory consultant to biotechn ology and pharmaceutical companies. From 2013 to 2014, she was Senior Vice President, Regulatory Affairs and Compliance at Esperion Therapeutics, and …
Prothena to Highlight Next Generation Treatments for Alzheimer
WebbProthena Biosciences Neotope Biosciences Ltd Revenue $201.6 M Employees 82 Primary Industries Pharmaceuticals Manufacturing Research & Development Business Services Funding History Prothena raised a total of $122.1 M in funding over 1 rounds, and is a public traded company. CEO Gene Kinney Stock Symbol NASDAQ: PRTA Webb1 apr. 2024 · Prothena Corporation plc 5,583 followers 2d CEO Gene Kinney and John Carroll, along with a panel of experts in the field, recently shared a meaningful discussion on the promise of abeta (Aβ)... drugoi mir
Denbury CEO, Off The Charts: Bonds & Prothena CEO
Webb24 aug. 2024 · Prothena CEO breaks down the biotech firm’s clinical trial timeline for therapeutics Gene Kinney, the president and CEO of Prothena, explained on Tuesday’s … WebbChief Strategy Officer and Chief Financial Officer: Total Cash $730,852: Equity $1,310,627: Other $14,500: Total Compensation $2,055,979: Gene G. Kinney Ph.D. President and … Webb12 maj 2024 · The performance at Prothena Corporation plc (NASDAQ:PRTA) has been quite strong recently and CEO Gene Kinney has played a role in it. Shareholders will have … ravan maharaj